Quibim

Quibim is a company leading at the forefront of imaging biomarkers research in life sciences, pioneering the development of advanced algorithms that transform imaging data into actionable predictions in oncology, immunology, and neurology. The company was founded with the ambition to leverage imaging as a catalyst for precision medicine, improving clinical outcomes for patients and redefining medical treatment and monitoring. Quibim utilizes MRI, CT, and PET imaging technologies to develop regulatory-cleared medical devices, integrating seamlessly into global healthcare workflows.